Notably, a recent study demonstrated that inflammatory/ISG-enriched monocytes promoted the expansion of tumor-specific CD8+ T cells and amplify antitumor immunity; transcriptionally, these monocytes were highly congruent with our ISGhigh subset (33). The gene discussed is CD8A; the disease is neoplasm.